NSRX Stock Analysis: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$3.07
-0.01 (-0.32%)
▼
5d:
-3.15%
30d:
+13.7%
90d:
+23.79%
BUY
MODERATE Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Jun 24, 2026
1d
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NSRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NSRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $3.07, which is considered fair relative to its 30-day fair value range of $2.83 to $3.19.
Technical Outlook: Technically, NSRX is in a strong downtrend. Immediate support is located at $2.83, while resistance sits at $3.68.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.67 (+540.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NSRX is in a strong downtrend. Immediate support is located at $2.83, while resistance sits at $3.68.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.67 (+540.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.83 -
$3.19
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 540.6% below Wall St target ($19.67)
Trading Range Analysis
30-Day Trading Range
$2.83 -
$3.19
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.83
Resistance Level
$3.68
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.33
Wall Street Target
$19.67
(+540.6%)
Share & Embed Analysis
Last updated: June 22, 2026 1:12 AM ET
Data refreshes hourly during market hours. Next update: 2:12 AM
Data refreshes hourly during market hours. Next update: 2:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1219 | 56 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 58 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$254 | 57 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$220 | 58 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$353 | 53 HOLD |